Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Summary

The National Institutes of Health (NIH) is seeking applications for a Genome Sequencing Center to support the Gabriella Miller Kids First Pediatric Research Program. This is a U24 cooperative agreement mechanism focused on pediatric research, explicitly excluding clinical trials. The opportunity is currently in a forecasted status, indicating a formal funding opportunity announcement (FOA) is anticipated but not yet published. The center would presumably provide large-scale genomic sequencing infrastructure and data generation in support of the Kids First program's mission to understand the genetic underpinnings of childhood cancers and structural birth defects.

What they want

How they evaluate

Risks & flags

• Forecasted notice only — full scope, eligibility, and evaluation criteria not yet published; limited ability to assess competitiveness
• U24 cooperative agreement mechanism typically awarded to large, established genomic centers, which may narrow the competitive field significantly
• No response date, budget, or evaluation criteria disclosed — insufficient information to fully assess procurement integrity